Luminex Corp. Company Profile (NASDAQ:LMNX)

Analyst Ratings

Consensus Ratings for Luminex Corp. (NASDAQ:LMNX) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $21.00 (2.01% downside)

Analysts' Ratings History for Luminex Corp. (NASDAQ:LMNX)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2016Jefferies GroupBoost Price TargetHold$21.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Piper Jaffray Cos.Reiterated RatingHold$19.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Leerink SwannReiterated RatingHold$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2016William BlairReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015JPMorgan Chase & Co.Boost Price TargetUnderweight$16.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015WedbushUpgradeNeutral -> Outperform$19.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015Cowen and CompanyBoost Price TargetMarket Perform$17.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014StephensDowngradeOverweight -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2014Citigroup Inc.Initiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Luminex Corp. (NASDAQ:LMNX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/1/2016        
7/28/2016Q216$0.15$0.33$61.20 million$64.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2016Q116$0.14$0.29$60.98 million$63.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/1/2016Q415$0.15$0.56$60.16 million$60.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2015Q315$0.11$0.22$57.24 million$60.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2015Q215$0.11$0.27$57.01 million$58.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015Q115$0.12$0.23$56.50 million$57.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2015Q414$0.12$0.19$58.31 million$58.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014Q314$0.10$0.27$56.60 million$56.68 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2014Q214$0.10$0.20$55.90 million$55.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2014Q114$0.12$0.24$55.31 million$56.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2014Q413$0.07$0.21$56.63 million$55.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2013Q313$0.11$0.02$54.67 million$50.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2013Q2 2013$0.10$0.17$54.16 million$54.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2013Q1 2013$0.08$0.19$51.94 million$53.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2013Q4 2012$0.08$0.12$54.09 million$55.53 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2012Q312$0.06$0.04$51.26 million$50.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2012$0.08$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2012$0.09$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2012$0.07$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.05$0.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2011$0.06$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011$0.06$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2011$0.05$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Luminex Corp. (NASDAQ:LMNX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.13$0.14$0.14
Q2 20163$0.14$0.19$0.17
Q3 20163$0.13$0.19$0.15
Q4 20163$0.14$0.18$0.16
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Luminex Corp. (NASDAQ:LMNX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Luminex Corp. (NASDAQ:LMNX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
1/4/2016G Walter Loewenbaum IIDirectorSell41,056$20.53$842,879.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2015G Walter Loewenbaum IIDirectorSell18,944$21.65$410,137.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Russell W. BradleyCMOSell6,514$22.75$148,193.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Nachum ShamirCEOBuy6,000$16.73$100,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015G Walter Loewenbaum IIDirectorBuy38,966$16.71$651,121.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Fred C Goad JrDirectorSell25,000$15.46$386,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2014Russell W BradleySVPSell5,000$20.50$102,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Patrick BalthropCEOSell70,000$17.69$1,238,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Kevin McnamaraDirectorSell5,000$17.95$89,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2014Jim KeverDirectorSell5,000$17.52$87,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2014Patrick BalthropCEOSell32,575$17.63$574,297.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Patrick BalthropCEOSell60,000$18.28$1,096,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014Fred Goad, Jr.DirectorSell50,000$18.86$943,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2014Patrick BalthropCEOSell55,000$19.05$1,047,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014David ReiterSVPSell15,000$19.09$286,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Harriss CurrieCFOSell11,000$19.08$209,880.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2013Harriss CurrieCFOSell30,000$19.88$596,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2013Harriss CurrieCFOSell30,000$19.87$596,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Michael PintekSVPSell3,000$20.00$60,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013G Walter Loewenbaum IIDirectorBuy6,034$20.62$124,421.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013G Walter Loewenbaum IIDirectorBuy20,000$20.76$415,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Timothy DehneVPSell32,297$20.66$667,256.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013G Walter Loewenbaum IIDirectorBuy10,000$20.82$208,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Timothy DehneVPSell1,793$21.21$38,029.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013G Walter Loewenbaum IIDirectorBuy4,600$21.17$97,382.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013G Walter Loewenbaum IIDirectorBuy27,000$20.01$540,270.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/2/2013Patrick J BalthropCEOSell68,048$20.01$1,361,640.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013David S ReiterSVPSell15,000$20.00$300,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Thomas W EricksonDirectorSell20,000$20.00$400,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Fred C Goad JrDirectorBuy11,250$18.25$205,312.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013G Walter Loewenbaum IIDirectorBuy13,000$18.37$238,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Fred C Goad JrDirectorBuy8,000$18.18$145,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013G Walter Loewenbaum IIDirectorBuy39,500$18.32$723,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013David S ReiterSVPSell10,000$18.26$182,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013G Walter Loewenbaum IIDirectorBuy19,000$18.13$344,470.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2013G Walter Loewenbaum IIDirectorBuy28,300$17.21$487,043.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2013G Walter Loewenbaum IIDirectorBuy64,935$17.17$1,114,933.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/3/2013G Walter Loewenbaum IIDirectorBuy24,765$17.02$421,500.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012David S ReiterVPSell10,000$20.00$200,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Luminex Corp. (NASDAQ:LMNX)
DateHeadline
07/29/16 07:56 AMLuminex : posts 2Q profit
07/29/16 07:30 AMLuminex Corp Earnings Call scheduled for 8:30 am ET today -
07/28/16 05:32 PMLuminex posts 2Q profit -
07/28/16 05:08 PMLuminex : Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time
07/28/16 03:31 PMLUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
07/28/16 06:07 AMQ2 2016 Luminex Corp Earnings Release - After Market Close -
07/20/16 09:30 PMStock is unchanged at $22.12 (LMNX) Luminex Corporation Second Quarter…
07/20/16 07:33 AM8:33 am Luminex alters 2Q16 conference call date/time to July 29 at 8:30 am ET from July 28 at 4:30 pm ET -
07/20/16 07:30 AMLuminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time - [PR Newswire] - AUSTIN, Texas, July 20, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it will now hold a conference call to discuss the second quarter operating highlights and financial ...
07/14/16 08:33 AMLuminex Corporation (LMNX) is Trading Higher on Unusual Volume for July 12
07/08/16 07:41 AMLuminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System - [at noodls] - AUSTIN, Texas, July 6, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced it has received FDA clearance and CE-IVD marking for a new in vitro diagnostic system, the ARIES M1 System. ...
07/08/16 07:30 AMLuminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016 - [PR Newswire] - AUSTIN, Texas, July 8, 2016 /PRNewswire/ -- Luminex Corporation (LMNX) today announced that it expects to report results for the second quarter ended June 30, 2016 on Thursday, July 28, 2016. This reporting date is earlier than usual as a result of the timing of the American Association for Clinical Chemistry's annual conference to be held in Philadelphia from July 31 through August 4. The conference call will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.
07/06/16 06:57 AMLuminex Gets FDA Approval And CE-IVD Mark For Its ARIES M1 System -
07/04/16 09:07 AMLuminex Closes Nanosphere Buyout, Maintains FY16 View -
07/02/16 07:49 AMLuminex : To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
07/02/16 07:49 AMForm SC TO-T/A NANOSPHERE INC Filed by: LUMINEX CORP
07/02/16 07:49 AMLuminex Corporation (LMNX) is Trading Higher on Unusual Volume for June 30
07/01/16 07:22 AMLuminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : July 1, 2016 -
06/30/16 01:19 PMLUMINEX CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibit -
06/30/16 08:21 AMLuminex Corporation To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference - [at noodls] - AUSTIN, Texas, June 22, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at Cantor Fitzgerald's 2 Annual Healthcare Conference to be held July 12 -13, ...
06/30/16 07:55 AMLuminex Corporation Completes Acquisition of Nanosphere, Inc. - [PR Newswire] - AUSTIN, Texas, June 30, 2016 /PRNewswire/ -- Luminex Corporation (LMNX) today announced that Luminex has completed its previously announced acquisition of Nanosphere, Inc. (NSPH). "We are pleased to announce the completion of this transaction and welcome the Nanosphere team to the Luminex family.
06/21/16 10:31 AMLuminex Corp. – Value Analysis (NASDAQ:LMNX) : June 21, 2016 -
06/20/16 07:30 AMLuminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : June 20, 2016 -
06/02/16 07:47 AMIncreased Earnings Estimates Seen for Luminex (LMNX): Can It Move Higher? -
06/02/16 07:04 AMLuminex's ARIES Flu A/B & RSV Assay Now CE-IVD Marked -
06/02/16 05:25 AMLuminex Corporation Receives CE-IVD Mark for ARIES Flu A/B & RSV Assay - [at noodls] - AUSTIN, Texas, June 1, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices for ...
06/02/16 05:00 AMLuminex Corporation Announces Commencement of Tender Offer for All Outstanding Shares of Nanosphere, Inc. Common Stock - [PR Newswire] - AUSTIN, Texas, June 2, 2016 /PRNewswire/ -- Luminex Corporation (LMNX) announced today that its wholly-owned subsidiary Commodore Acquisition, Inc. has commenced its previously announced tender offer to purchase all outstanding shares of common stock of Nanosphere, Inc. (NSPH) for $1.70 per share in cash. The tender offer is being made pursuant to the Agreement and Plan of Merger entered into and among Luminex, Commodore, and Nanosphere dated May 15, 2016 as subsequently amended.
06/01/16 11:57 AMLuminex Gets CE-IVD Mark For ARIES Flu A/B & RSV Assay - Luminex Corporation (NASDAQ: LMNX) disclosed Wednesday that it received CE-IVD status under the European Directive on In Vitro Diagnostic Medical Devices for the ARIES Flu A/B & RSV Assay. The company added that it was meant for use with the FDA cleared and CE-IVD marked ARIES System. The company indicated the ARIES Flu A/B & RSV Assay was a rapid and accurate method for the detection and ...Full story available on Benzinga.com
05/30/16 09:27 AMHC Stock to Path: Nanosphere, Inc. (NASDAQ:NSPH), Eli Lilly and Co (NYSE:LLY) - share market updates (press release) - HC Stock to Path: Nanosphere, Inc. (NASDAQ:NSPH), Eli Lilly and Co (NYSE:LLY)share market updates (press release)On May 23, 2016 – Luminex Corporation (LMNX) and Nanosphere, Inc. (NSPH) announced that they have entered into an amendment to the definitive agreement under which Luminex will acquire Nanosphere, a leader in the molecular microbiology and ...and more »
05/27/16 09:18 AMLuminex Corporation To Present At Jefferies 2016 Healthcare Conference - PR Newswire (press release) - Luminex Corporation To Present At Jefferies 2016 Healthcare ConferencePR Newswire (press release)AUSTIN, Texas, May 26, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Jefferies 2016 Healthcare Conference to be held June 7-10, 2016, in New York, NY. The investor presentation will ...and more »
05/26/16 03:05 PMLuminex Corporation To Present At Jefferies 2016 Healthcare Conference - [PR Newswire] - AUSTIN, Texas, May 26, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Jefferies 2016 Healthcare Conference to be held June 7-10, 2016, in New ...
05/23/16 11:03 AMMid-Morning Market Update: Markets Slightly Higher; Arbor Pharmaceuticals to Buy XenoPort For $7.03/Share - Nasdaq - Mid-Morning Market Update: Markets Slightly Higher; Arbor Pharmaceuticals to Buy XenoPort For $7.03/ShareNasdaqNanosphere, Inc. (NASDAQ: NSPH ) shares were also up, gaining 27 percent to $1.66 as Luminex Corporation (NASDAQ: LMNX ) raised its acquisition price for Nanosphere from $1.35 per share to $1.70 per share. The total transaction is now valued about ...and more »
05/23/16 11:03 AMMerger Monday Mania: It's the Market in 5 Minutes - Detroit Free Press - Merger Monday Mania: It's the Market in 5 MinutesDetroit Free PressTribune Publishing (NYSE: TPUB) rejected Gannett's (NYSE: GCI) latest $864 million takeover proposal, but will agree to share confidential information with the U.S. newspaper company. Luminex (NASDAQ: LMNX) and Nanosphere (NASDAQ: NSPH) have ...and more »
05/23/16 11:03 AMLuminex Sweetens Bid To Buy Nanosphere - Benzinga - TheStreet.comLuminex Sweetens Bid To Buy NanosphereBenzingaLuminex Corporation LMNX and Nanosphere, Inc. NSPH have announced an update on Acquisition Agreement. According to the companies, they have struck a definitive agreement under which the former will buy the latter. The Transaction is expected to be ...Luminex Corp. (LMNX), Nanosphere (NSPH) Amend Acquisition Agreement; Price Now at $1.70/ShareStreetInsider.comNanosphere (NSPH) Stock Surging as Luminex Ups BidTheStreet.comAre Nanosphere Shareholders Getting Enough With This New Offer?24/7 Wall St.Mass Device -Sonoran Weekly Reviewall 11 news articles »
05/23/16 09:49 AMNanosphere (NSPH) Stock Surging as Luminex Ups Bid -
05/23/16 09:45 AMAre Nanosphere Shareholders Getting Enough With This New Offer? -
05/23/16 07:43 AMLuminex Sweetens Bid To Buy Nanosphere - Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) have announced an update on Acquisition Agreement. According to the companies, they have struck a definitive agreement under which the former will buy the latter. The Transaction is expected to be accretive to its adjusted earnings by the end of the next year. Luminex said it has boosted the offer price to $1.70 a share from $1.35 a share in an all cash transaction. The total transaction is now valued about $77 million compared to $58 million at ...Full story available on Benzinga.com
05/23/16 06:43 AMBRIEF-Luminex says, upon termination of merger agreement, Nanosphere would have to pay termination fee of $2.25 mln - * Upon termination of merger agreement, under specified circumstances, Nanosphere would have been required to pay co termination fee of $2.25 million
05/23/16 05:26 AMLUMINEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat -
05/20/16 09:41 AMRevenue Update on Luminex Corporation(NASDAQ:LMNX) - Trade Calls - Revenue Update on Luminex Corporation(NASDAQ:LMNX)Trade CallsLuminex Corporation(NASDAQ:LMNX) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during After-hours on May 2, 2016. Company reported revenue of $62.98M. Analysts estimated a revenue of $60.98M. Earnings per ...Luminex Corporation (NASDAQ:LMNX) Shorted Shares Decreased By 2.49%The PostAre Analysts Bullish Luminex Corporation (NASDAQ:LMNX) After Last Week?Franklin IndependentAnalyst Recommendations On Luminex Corporation (NASDAQ:LMNX)News Tribuneall 5 news articles »
05/18/16 09:38 PMETF’s with exposure to Luminex Corp. : May 19, 2016 -
05/18/16 08:47 AMRodman & Renshaw Downgrades Nanosphere Following Luminex Acquisition - Rodman & Renshaw's Raghuram Selvaraju downgraded Nanosphere, Inc. (NASDAQ: NSPH) from Buy to Neutral, while decreasing the price target from $2.00 to $1.35. The rating change came after Luminex Corporation (NASDAQ: LMNX) announced it was acquiring Nanosphere for $1.35 a share in an all-cash transaction. Related Link: Here's Why Wells Fargo Doesn't Like Valeant's Big Bonuses Luminex plans to purchase ...Full story available on Benzinga.com
05/17/16 07:22 AMLuminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : May 17, 2016 -
05/17/16 07:02 AMLuminex (LMNX) to Buy Nanosphere, Eyes Portfolio Expansion -
05/16/16 05:43 PMNotable Mergers and Acquisitions 5/16: (PFE)/(ANAC) (RRC)/(MRD) (LMNX)/(NSPH) (LECO) (EQIX)/(DLR) - Morgan Stanley & Co LLC and Barclays Capital Inc. acted as financial advisors ... "The acquisition of Nanosphere will significantly enhance Luminex's growth trajectory by expanding our product portfolio, delivering access to new markets and strengthening ...
05/16/16 03:05 PMLuminex to Highlight Latest Additions to Product Portfolio at the 2016 Clinical Virology Symposium - [PR Newswire] - AUSTIN, Texas, May 16, 2016 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced it will highlight the latest additions to its product portfolio at the 32 nd Annual Clinical Virology Symposium, ...
05/16/16 02:40 PMLuminex looks to acquire Illinois biotech firm for $58M -
05/16/16 12:33 PMMid-Day Market Update: Nanosphere Jumps Following Luminex Deal; Breitburn Energy Partners Shares Drop - Midway through trading Monday, the Dow traded up 0.64 percent to 17,647.80 while the NASDAQ surged 0.81 percent to 4,756.09. The S&P also rose, gaining 0.63 percent to 2,059.54. Leading and Lagging Sectors Basic materials shares rose around 2.02 percent in trading on Monday. Top gainers in the sector included Bill Barrett Corporation (NYSE: BBG), Newpark Resources Inc (NYSE: NR), and Approach Resources Inc. (NASDAQ: AREX). In trading on Monday, utilities shares slipped by 0.1 percent. Meanwhile, top losers in the sector included Companhia Paranaense de Energia (ADR) (NYSE: ELP), down 3 percent, and TransAlta Corporation (USA) (NYSE: TAC), down 2 percent. Top Headline Pfizer Inc. (NYSE: PFE) announced plans to buy Anacor Pharmaceuticals Inc (NASDAQ: ANAC) for $99.25 per share in cash. The total transaction value, net of ...Full story available on Benzinga.com
05/16/16 11:05 AMLuminex Corp. (LMNX) to Acquire Nanosphere (NSPH) for $1.35/Share - StreetInsider.com - Washington TimesLuminex Corp. (LMNX) to Acquire Nanosphere (NSPH) for $1.35/ShareStreetInsider.comLuminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) today announced that the companies have entered into a definitive agreement under which Luminex will acquire Nanosphere, a leader in the molecular microbiology and ...Mid-Morning Market Update: Markets Open Higehr; Pfizer To Acquire Anacor Pharmaceuticals For $5.2BBenzingaall 84 news articles »
05/16/16 06:14 AMLUMINEX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, -

Social

About Luminex Corp.

Luminex Corp. logoLuminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to various types of testing laboratories. The Company's assay products are focused on three segments of the molecular diagnostic testing market: human genetics, personalized medicine and infectious disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: LMNX
  • CUSIP: 55027E10
Key Metrics:
  • Previous Close: $22.30
  • 50 Day Moving Average: $20.95
  • 200 Day Moving Average: $19.84
  • P/E Ratio: 25.37
  • P/E Growth: 0.59
  • Market Cap: $978.62M
  • Beta: 0.29
  • Current Year EPS Consensus Estimate: $0.67 EPS
  • Next Year EPS Consensus Estimate: $0.63 EPS
Additional Links:
Luminex Corp. (NASDAQ:LMNX) Chart for Friday, July, 29, 2016